Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis

Journal of Clinical Investigation

Volumn 120, Issue 3, 2010, Pages 850-858

  Bouzas Rodriguez, Jimena ^a   Cabrera, Jorge Ruben ^a   Delloye Bourgeois, Céline ^a   Ichim, Gabriel ^a   Delcros, Jean Guy ^a   Raquin, Marie Anne ^b   Rousseau, Raphaël ^a   Combaret, Valérie ^a   Bénard, Jean ^c   Tauszig Delamasure, Servane ^a   Mehlen, Patrick ^a  

^a UNIVERSITÉ DE LYON   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; LIGAND; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BREAST TUMOR; CANCER INHIBITION; CELL DEATH; CELL SURVIVAL; CHICKEN; ENZYME INHIBITION; ENZYME SYNTHESIS; GENE DISRUPTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INCUBATION TIME; METASTASIS; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; APOPTOSIS; AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; CELL SURVIVAL; CHICKENS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; NEUROTROPHIN 3; RECEPTOR, TRKC; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 77949764087     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI41013     Document Type: Article

References (52)

1. Levi-Montalcini R, Angeletti PU. Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev Biol. 1963;7:653-659.
2. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736.
3. Nakagawara A. Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett. 2001;169(2):107-114.
4. Porter AC, Vaillancourt RR. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene. 1998;17(11 Reviews):1343-1352.
5. Xu X, Tahan SR, Pasha TL, Zhang PJ. Expression of neurotrophin receptor Trk-C in nevi and melanomas. J Cutan Pathol. 2003;30(5):318-322.
6. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci U S A. 1994;91(26):12867-12871.
7. Grotzer MA, et al. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol. 2000;18(5):1027-1035.
8. Yamashiro DJ, Nakagawara A, Ikegaki N, Liu XG, Brodeur GM. Expression of TrkC in favorable human neuroblastomas. Oncogene. 1996;12(1):37-41.
9. Ryden M, Sehgal R, Dominici C, Schilling FH, Ibanez CF, Kogner P. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Br J Cancer. 1996;74(5):773-779.
10. Brodeur GM, et al. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol. 1997;31(1-2):49-55.
11. Yamashiro DJ, et al. Expression and function of Trk-C in favourable human neuroblastomas. Eur J Cancer. 1997;33(12):2054-2057.
12. Svensson T, et al. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma. Eur J Cancer. 1997;33(12):2058-2063.
13. Kim JY, et al. Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res. 1999;59(3):711-719.
14. Tauszig-Delamasure S, et al. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc Natl Acad Sci U S A. 2007;104(33):13361-13366.
15. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature. 1998;395(6704):801-804.
16. Mehlen P, Thibert C. Dependence receptors: between life and death. Cell Mol Life Sci. 2004;61(15):1854-1866.
17. Matsunaga E, et al. RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol. 2004;6(8):749-755.
18. Bordeaux MC, et al. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J. 2000;19(15):4056-4063.
19. Furne C, et al. EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis. Biochim Biophys Acta. 2009;1793(2):231-238.
20. Mourali J, et al. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol Cell Biol. 2006;26(16):6209-6222.
21. Mehlen P, Bredesen DE. The dependence receptor hypothesis. Apoptosis. 2004;9(1):37-49.
22. Thibert C, Teillet MA, Lapointe F, Mazelin L, Le Douarin NM, Mehlen P. Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog. Science. 2003;301(5634):843-846.
23. Furne C, Rama N, Corset V, Chedotal A, Mehlen P. Netrin-1 is a survival factor during commissural neuron navigation. Proc Natl Acad Sci U S A. 2008;105(38):14465-14470.
24. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6(6):449-458.
25. Grady WM. Making the case for DCC and UNC5C as tumor-suppressor genes in the colon. Gastroenterology. 2007;133(6):2045-2049.
26. Mazelin L, et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature. 2004;431(7004):80-84.
27. Bernet A, et al. Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology. 2007;133(6):1840-1848.
28. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159-170.
29. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369(9579):2106-2120.
30. Stupack DG, et al. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature. 2006;439(7072):95-99.
31. Delloye-Bourgeois C, et al. Interference with netrin-1 and tumor cell death in non-small cell lung cancer. J Natl Cancer Inst. 2009;101(4):237-247.
32. Delloye-Bourgeois C, et al. Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med. 2009;206(4):833-847.
33. Marchetti D, Nicolson GL. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Adv Enzyme Regul. 1997;37:111-134.
34. Innominato PF, Libbrecht L, van den Oord JJ. Expression of neurotrophins and their receptors in pigment cell lesions of the skin. J Pathol. 2001;194(1):95-100.
35. Truzzi F, et al. Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Invest Dermatol. 2008;128(8):2031- 2040.
36. Calatozzolo C, et al. Expression of cannabinoid receptors and neurotrophins in human gliomas. Neurol Sci. 2007;28(6):304-310.
37. Hisaoka M, Sheng WQ, Tanaka A, Hashimoto H. Gene expression of TrkC (NTRK3) in human soft tissue tumours. J Pathol. 2002;197(5):661-667.
38. Weeraratna AT, Arnold JT, George DJ, DeMarzo A, Isaacs JT. Rational basis for Trk inhibition therapy for prostate cancer. Prostate. 2000;45(2):140-148.
39. Satoh F, et al. Autocrine expression of neurotrophins and their receptors in prostate cancer. Int J Urol. 2001;8(7):S28-34.
40. Miknyoczki SJ, et al. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice. Clin Cancer Res. 2002;8(6):1924-1931.
41. Ketterer K, Rao S, Friess H, Weiss J, Buchler MW, Korc M. Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res. 2003;9(14):5127-5136.
42. Sakamoto Y, et al. Expression of Trk tyrosine kinase receptor is a biologic marker for cell proliferation and perineural invasion of human pancreatic ductal adenocarcinoma. Oncol Rep. 2001;8(3):477-484.
43. Ohta T, et al. Neurotrophin-3 expression in human pancreatic cancers. J Pathol. 1997;181(4):405-412.
44. Du JJ, et al. Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study. World J Gastroenterol. 2003;9(7):1431-1434.
45. Ricci A, et al. Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol. 2001;25(4):439-446.
46. Blasco-Gutierrez MJ, et al. TrkC: a new predictive marker in breast cancer? Cancer Invest. 2007;25(6):405-410.
47. McGregor LM, et al. Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. Proc Natl Acad Sci U S A. 1999;96(8):4540-4545.
48. Nakagawara A, Brodeur GM. Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study. Eur J Cancer. 1997;33(12):2050-2053.
49. Marchetti D, Nicolson GL. Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity. J Investig Dermatol Symp Proc. 1997;2(1):99-105.
50. Sinnappah-Kang ND, Kaiser AJ, Blust BE, Mrak RE, Marchetti D. Heparanase, TrkC and p75NTR: their functional involvement in human medulloblastoma cell invasion. Int J Oncol. 2005;27(3):617-626.
51. Sinnappah-Kang ND, Mrak RE, Paulsen DB, Marchetti D. Heparanase expression and TrkC/ p75NTR ratios in human medulloblastoma. Clin Exp Metastasis. 2006;23(1):55-63.
52. Ghoumari AM, Wehrle R, Bernard O, Sotelo C, Dusart I. Implication of Bcl-2 and Caspase-3 in age-related Purkinje cell death in murine organotypic culture: an in vitro model to study apoptosis. Eur J Neurosci. 2000;12(8):2935-2949.